Deals
Cipla has paid Tata Industries around $12.5m for Inzpera Healthsciences to grow its consumer health portfolio.
Karo will take on responsibility for the marketing, distribution and sales of Moberg’s topical onychomycosis treatment, MOB-15, under the Lamisil brand in 19 European countries.
Kenvue share price on downward trend since its highly anticipated spinout from J&J in 2023.
Kenvue’s latest results could be a sign of things to come for other consumer health product businesses launched as spinouts from pharmaceutical giants. Along with its third-quarter results on Nov. 3, Kenvue announces deal to be acquired by Kimberly-Clark.
“Incredible rigor, thoughtfulness and discipline” went into Kleenex tissues, Huggies disposable diapers, and Kotex tampons marketer Kimberly-Clark’s $48.7bn offer for Kenvue, the former J&J consumer health products business on its own for two years.
A rising demand for eco-certified skin care products attracted Archimed to invest in Denmark's DermaPharm, which markets the Avivir and DermaKnowlogy brands.
Smoking cessation brand Nicotinell is now under the ownership of Dr Reddy's in Germany, where the firm is hoping to lay the foundations for future growth in the consumer health market.
Stada is set for new ownership after CapVest agreed to buy a controlling stake from Bain Capital and Cinven. CapVest is pledging to “deploy significant new capital” to advance Stada’s interests, with the German giant’s CEO hinting at “ambitious plans” for the future.
PCH lowers full-year guidance even after reaching $100m deal to acquire Canadian sterile ophthalmic manufacturer for its Clears Eyes line troubled by supply slumps for several years. Its $47.5m reported net sales for April-June period were down 6% from a year ago.
Navamedic adds Ventizolve to its portfolio shortly after Norway switched the opioid overdose reversal drug from Rx to OTC.
Advent International is poised to take control of Reckitt's Essential Home business, but the UK-based firm will retain a 30% stake.
Perrigo stands to gain up to €327m with sale of brands such as ACO and Emolium to KKR.
Haleon finalizes deal to make its China joint venture a wholly-owned subsidiary in move to "drive category growth in one of the fastest growing OTC markets globally."
Norway's Navamedic will move into the addiction treatment market with the acquisition of DNE Pharma, adding to its portfolio an OTC opioid overdose reversal spray.
A healthy diversity of different types of players and plenty of space for scaling up are among the reasons that investors remain interested in the consumer health sector, according to investment bankers speaking at the recent AESGP Annual Meeting.
Consumer health player PharmaSGP will be taken private by its biggest shareholder, FUTRUE.
Private equity firms now in control of Alliance Pharma weighing úp plan to offload Rx business to help finance strategy to drive up sales and growth.
Deal totaling as much as $880m extends C&D into additional product category with a brand it says is the fastest growing in the US hand sanitizer category and No. 2 brand in the category overall.
UK-based Venture Life is divesting its CDMO business and some non-core products to focus its attention on growing its consumer health operation.
Private equity firm CD&R takes control of Opella while Sanofi retains a sizeable stake and nets €10bn.